img

Global Atosiban Acetate Injection Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Atosiban Acetate Injection Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Atosiban Acetate Injection is a tocolytic that can be used in IVF to protect the pregnancy, and the principle of action is to prevent the increase of calcium ions in the cells, relax the smooth muscle of the uterus, reduce uterine contractions and help embryo implantation.
Atosiban Acetate Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Atosiban Acetate Injection market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Threatened Preterm Birth and Inhibits Lactation are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Atosiban Acetate Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Atosiban Acetate Injection key manufacturers include Bachem, Piramal Pharma Solutions, Transo-Pharm, Rochem International, Suanfarma, Teva Pharmaceutical Industries, PolyPeptide Group, Emcure Pharmaceuticals and Smaart Pharmaceutticals, etc. Bachem, Piramal Pharma Solutions, Transo-Pharm are top 3 players and held % sales share in total in 2022.
Atosiban Acetate Injection can be divided into 0.9 ml and 5 ml, etc. 0.9 ml is the mainstream product in the market, accounting for % sales share globally in 2022.
Atosiban Acetate Injection is widely used in various fields, such as Threatened Preterm Birth, Inhibits Lactation and Others,, etc. Threatened Preterm Birth provides greatest supports to the Atosiban Acetate Injection industry development. In 2022, global % sales of Atosiban Acetate Injection went into Threatened Preterm Birth filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Atosiban Acetate Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Bachem
Piramal Pharma Solutions
Transo-Pharm
Rochem International
Suanfarma
Teva Pharmaceutical Industries
PolyPeptide Group
Emcure Pharmaceuticals
Smaart Pharmaceutticals
Omgene Life Sciences
BCN Peptides
MSN Laboratories
Carbosynth
Tecoland
Jigs Chemical
LGM Pharma
Hangzhou Go Top Peptide Biotech
Sun Pharmaceutical lndustrie
Hainan Zhonghe
Shanghai SOHO YIMING
Hybio Pharmaceutical
Hainan Herui
Chengdu Shengnuo
Segment by Type
0.9 ml
5 ml

Segment by Application


Threatened Preterm Birth
Inhibits Lactation
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Atosiban Acetate Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Atosiban Acetate Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Atosiban Acetate Injection industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Atosiban Acetate Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Atosiban Acetate Injection introduction, etc. Atosiban Acetate Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Atosiban Acetate Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Atosiban Acetate Injection Market Overview
1.1 Atosiban Acetate Injection Product Overview
1.2 Atosiban Acetate Injection Market Segment by Type
1.2.1 0.9 ml
1.2.2 5 ml
1.3 Global Atosiban Acetate Injection Market Size by Type
1.3.1 Global Atosiban Acetate Injection Market Size Overview by Type (2024-2034)
1.3.2 Global Atosiban Acetate Injection Historic Market Size Review by Type (2024-2024)
1.3.3 Global Atosiban Acetate Injection Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Atosiban Acetate Injection Sales Breakdown by Type (2024-2024)
1.4.2 Europe Atosiban Acetate Injection Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Atosiban Acetate Injection Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Atosiban Acetate Injection Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Atosiban Acetate Injection Sales Breakdown by Type (2024-2024)
2 Global Atosiban Acetate Injection Market Competition by Company
2.1 Global Top Players by Atosiban Acetate Injection Sales (2024-2024)
2.2 Global Top Players by Atosiban Acetate Injection Revenue (2024-2024)
2.3 Global Top Players by Atosiban Acetate Injection Price (2024-2024)
2.4 Global Top Manufacturers Atosiban Acetate Injection Manufacturing Base Distribution, Sales Area, Product Type
2.5 Atosiban Acetate Injection Market Competitive Situation and Trends
2.5.1 Atosiban Acetate Injection Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Atosiban Acetate Injection Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Atosiban Acetate Injection as of 2022)
2.7 Date of Key Manufacturers Enter into Atosiban Acetate Injection Market
2.8 Key Manufacturers Atosiban Acetate Injection Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Atosiban Acetate Injection Status and Outlook by Region
3.1 Global Atosiban Acetate Injection Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Atosiban Acetate Injection Historic Market Size by Region
3.2.1 Global Atosiban Acetate Injection Sales in Volume by Region (2024-2024)
3.2.2 Global Atosiban Acetate Injection Sales in Value by Region (2024-2024)
3.2.3 Global Atosiban Acetate Injection Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Atosiban Acetate Injection Forecasted Market Size by Region
3.3.1 Global Atosiban Acetate Injection Sales in Volume by Region (2024-2034)
3.3.2 Global Atosiban Acetate Injection Sales in Value by Region (2024-2034)
3.3.3 Global Atosiban Acetate Injection Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Atosiban Acetate Injection by Application
4.1 Atosiban Acetate Injection Market Segment by Application
4.1.1 Threatened Preterm Birth
4.1.2 Inhibits Lactation
4.1.3 Others
4.2 Global Atosiban Acetate Injection Market Size by Application
4.2.1 Global Atosiban Acetate Injection Market Size Overview by Application (2024-2034)
4.2.2 Global Atosiban Acetate Injection Historic Market Size Review by Application (2024-2024)
4.2.3 Global Atosiban Acetate Injection Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Atosiban Acetate Injection Sales Breakdown by Application (2024-2024)
4.3.2 Europe Atosiban Acetate Injection Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Atosiban Acetate Injection Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Atosiban Acetate Injection Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Atosiban Acetate Injection Sales Breakdown by Application (2024-2024)
5 North America Atosiban Acetate Injection by Country
5.1 North America Atosiban Acetate Injection Historic Market Size by Country
5.1.1 North America Atosiban Acetate Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Atosiban Acetate Injection Sales in Volume by Country (2024-2024)
5.1.3 North America Atosiban Acetate Injection Sales in Value by Country (2024-2024)
5.2 North America Atosiban Acetate Injection Forecasted Market Size by Country
5.2.1 North America Atosiban Acetate Injection Sales in Volume by Country (2024-2034)
5.2.2 North America Atosiban Acetate Injection Sales in Value by Country (2024-2034)
6 Europe Atosiban Acetate Injection by Country
6.1 Europe Atosiban Acetate Injection Historic Market Size by Country
6.1.1 Europe Atosiban Acetate Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Atosiban Acetate Injection Sales in Volume by Country (2024-2024)
6.1.3 Europe Atosiban Acetate Injection Sales in Value by Country (2024-2024)
6.2 Europe Atosiban Acetate Injection Forecasted Market Size by Country
6.2.1 Europe Atosiban Acetate Injection Sales in Volume by Country (2024-2034)
6.2.2 Europe Atosiban Acetate Injection Sales in Value by Country (2024-2034)
7 Asia-Pacific Atosiban Acetate Injection by Region
7.1 Asia-Pacific Atosiban Acetate Injection Historic Market Size by Region
7.1.1 Asia-Pacific Atosiban Acetate Injection Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Atosiban Acetate Injection Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Atosiban Acetate Injection Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Atosiban Acetate Injection Forecasted Market Size by Region
7.2.1 Asia-Pacific Atosiban Acetate Injection Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Atosiban Acetate Injection Sales in Value by Region (2024-2034)
8 Latin America Atosiban Acetate Injection by Country
8.1 Latin America Atosiban Acetate Injection Historic Market Size by Country
8.1.1 Latin America Atosiban Acetate Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Atosiban Acetate Injection Sales in Volume by Country (2024-2024)
8.1.3 Latin America Atosiban Acetate Injection Sales in Value by Country (2024-2024)
8.2 Latin America Atosiban Acetate Injection Forecasted Market Size by Country
8.2.1 Latin America Atosiban Acetate Injection Sales in Volume by Country (2024-2034)
8.2.2 Latin America Atosiban Acetate Injection Sales in Value by Country (2024-2034)
9 Middle East and Africa Atosiban Acetate Injection by Country
9.1 Middle East and Africa Atosiban Acetate Injection Historic Market Size by Country
9.1.1 Middle East and Africa Atosiban Acetate Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Atosiban Acetate Injection Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Atosiban Acetate Injection Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Atosiban Acetate Injection Forecasted Market Size by Country
9.2.1 Middle East and Africa Atosiban Acetate Injection Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Atosiban Acetate Injection Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Bachem
10.1.1 Bachem Company Information
10.1.2 Bachem Introduction and Business Overview
10.1.3 Bachem Atosiban Acetate Injection Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Bachem Atosiban Acetate Injection Products Offered
10.1.5 Bachem Recent Development
10.2 Piramal Pharma Solutions
10.2.1 Piramal Pharma Solutions Company Information
10.2.2 Piramal Pharma Solutions Introduction and Business Overview
10.2.3 Piramal Pharma Solutions Atosiban Acetate Injection Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Piramal Pharma Solutions Atosiban Acetate Injection Products Offered
10.2.5 Piramal Pharma Solutions Recent Development
10.3 Transo-Pharm
10.3.1 Transo-Pharm Company Information
10.3.2 Transo-Pharm Introduction and Business Overview
10.3.3 Transo-Pharm Atosiban Acetate Injection Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Transo-Pharm Atosiban Acetate Injection Products Offered
10.3.5 Transo-Pharm Recent Development
10.4 Rochem International
10.4.1 Rochem International Company Information
10.4.2 Rochem International Introduction and Business Overview
10.4.3 Rochem International Atosiban Acetate Injection Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Rochem International Atosiban Acetate Injection Products Offered
10.4.5 Rochem International Recent Development
10.5 Suanfarma
10.5.1 Suanfarma Company Information
10.5.2 Suanfarma Introduction and Business Overview
10.5.3 Suanfarma Atosiban Acetate Injection Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Suanfarma Atosiban Acetate Injection Products Offered
10.5.5 Suanfarma Recent Development
10.6 Teva Pharmaceutical Industries
10.6.1 Teva Pharmaceutical Industries Company Information
10.6.2 Teva Pharmaceutical Industries Introduction and Business Overview
10.6.3 Teva Pharmaceutical Industries Atosiban Acetate Injection Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Teva Pharmaceutical Industries Atosiban Acetate Injection Products Offered
10.6.5 Teva Pharmaceutical Industries Recent Development
10.7 PolyPeptide Group
10.7.1 PolyPeptide Group Company Information
10.7.2 PolyPeptide Group Introduction and Business Overview
10.7.3 PolyPeptide Group Atosiban Acetate Injection Sales, Revenue and Gross Margin (2024-2024)
10.7.4 PolyPeptide Group Atosiban Acetate Injection Products Offered
10.7.5 PolyPeptide Group Recent Development
10.8 Emcure Pharmaceuticals
10.8.1 Emcure Pharmaceuticals Company Information
10.8.2 Emcure Pharmaceuticals Introduction and Business Overview
10.8.3 Emcure Pharmaceuticals Atosiban Acetate Injection Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Emcure Pharmaceuticals Atosiban Acetate Injection Products Offered
10.8.5 Emcure Pharmaceuticals Recent Development
10.9 Smaart Pharmaceutticals
10.9.1 Smaart Pharmaceutticals Company Information
10.9.2 Smaart Pharmaceutticals Introduction and Business Overview
10.9.3 Smaart Pharmaceutticals Atosiban Acetate Injection Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Smaart Pharmaceutticals Atosiban Acetate Injection Products Offered
10.9.5 Smaart Pharmaceutticals Recent Development
10.10 Omgene Life Sciences
10.10.1 Omgene Life Sciences Company Information
10.10.2 Omgene Life Sciences Introduction and Business Overview
10.10.3 Omgene Life Sciences Atosiban Acetate Injection Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Omgene Life Sciences Atosiban Acetate Injection Products Offered
10.10.5 Omgene Life Sciences Recent Development
10.11 BCN Peptides
10.11.1 BCN Peptides Company Information
10.11.2 BCN Peptides Introduction and Business Overview
10.11.3 BCN Peptides Atosiban Acetate Injection Sales, Revenue and Gross Margin (2024-2024)
10.11.4 BCN Peptides Atosiban Acetate Injection Products Offered
10.11.5 BCN Peptides Recent Development
10.12 MSN Laboratories
10.12.1 MSN Laboratories Company Information
10.12.2 MSN Laboratories Introduction and Business Overview
10.12.3 MSN Laboratories Atosiban Acetate Injection Sales, Revenue and Gross Margin (2024-2024)
10.12.4 MSN Laboratories Atosiban Acetate Injection Products Offered
10.12.5 MSN Laboratories Recent Development
10.13 Carbosynth
10.13.1 Carbosynth Company Information
10.13.2 Carbosynth Introduction and Business Overview
10.13.3 Carbosynth Atosiban Acetate Injection Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Carbosynth Atosiban Acetate Injection Products Offered
10.13.5 Carbosynth Recent Development
10.14 Tecoland
10.14.1 Tecoland Company Information
10.14.2 Tecoland Introduction and Business Overview
10.14.3 Tecoland Atosiban Acetate Injection Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Tecoland Atosiban Acetate Injection Products Offered
10.14.5 Tecoland Recent Development
10.15 Jigs Chemical
10.15.1 Jigs Chemical Company Information
10.15.2 Jigs Chemical Introduction and Business Overview
10.15.3 Jigs Chemical Atosiban Acetate Injection Sales, Revenue and Gross Margin (2024-2024)
10.15.4 Jigs Chemical Atosiban Acetate Injection Products Offered
10.15.5 Jigs Chemical Recent Development
10.16 LGM Pharma
10.16.1 LGM Pharma Company Information
10.16.2 LGM Pharma Introduction and Business Overview
10.16.3 LGM Pharma Atosiban Acetate Injection Sales, Revenue and Gross Margin (2024-2024)
10.16.4 LGM Pharma Atosiban Acetate Injection Products Offered
10.16.5 LGM Pharma Recent Development
10.17 Hangzhou Go Top Peptide Biotech
10.17.1 Hangzhou Go Top Peptide Biotech Company Information
10.17.2 Hangzhou Go Top Peptide Biotech Introduction and Business Overview
10.17.3 Hangzhou Go Top Peptide Biotech Atosiban Acetate Injection Sales, Revenue and Gross Margin (2024-2024)
10.17.4 Hangzhou Go Top Peptide Biotech Atosiban Acetate Injection Products Offered
10.17.5 Hangzhou Go Top Peptide Biotech Recent Development
10.18 Sun Pharmaceutical lndustrie
10.18.1 Sun Pharmaceutical lndustrie Company Information
10.18.2 Sun Pharmaceutical lndustrie Introduction and Business Overview
10.18.3 Sun Pharmaceutical lndustrie Atosiban Acetate Injection Sales, Revenue and Gross Margin (2024-2024)
10.18.4 Sun Pharmaceutical lndustrie Atosiban Acetate Injection Products Offered
10.18.5 Sun Pharmaceutical lndustrie Recent Development
10.19 Hainan Zhonghe
10.19.1 Hainan Zhonghe Company Information
10.19.2 Hainan Zhonghe Introduction and Business Overview
10.19.3 Hainan Zhonghe Atosiban Acetate Injection Sales, Revenue and Gross Margin (2024-2024)
10.19.4 Hainan Zhonghe Atosiban Acetate Injection Products Offered
10.19.5 Hainan Zhonghe Recent Development
10.20 Shanghai SOHO YIMING
10.20.1 Shanghai SOHO YIMING Company Information
10.20.2 Shanghai SOHO YIMING Introduction and Business Overview
10.20.3 Shanghai SOHO YIMING Atosiban Acetate Injection Sales, Revenue and Gross Margin (2024-2024)
10.20.4 Shanghai SOHO YIMING Atosiban Acetate Injection Products Offered
10.20.5 Shanghai SOHO YIMING Recent Development
10.21 Hybio Pharmaceutical
10.21.1 Hybio Pharmaceutical Company Information
10.21.2 Hybio Pharmaceutical Introduction and Business Overview
10.21.3 Hybio Pharmaceutical Atosiban Acetate Injection Sales, Revenue and Gross Margin (2024-2024)
10.21.4 Hybio Pharmaceutical Atosiban Acetate Injection Products Offered
10.21.5 Hybio Pharmaceutical Recent Development
10.22 Hainan Herui
10.22.1 Hainan Herui Company Information
10.22.2 Hainan Herui Introduction and Business Overview
10.22.3 Hainan Herui Atosiban Acetate Injection Sales, Revenue and Gross Margin (2024-2024)
10.22.4 Hainan Herui Atosiban Acetate Injection Products Offered
10.22.5 Hainan Herui Recent Development
10.23 Chengdu Shengnuo
10.23.1 Chengdu Shengnuo Company Information
10.23.2 Chengdu Shengnuo Introduction and Business Overview
10.23.3 Chengdu Shengnuo Atosiban Acetate Injection Sales, Revenue and Gross Margin (2024-2024)
10.23.4 Chengdu Shengnuo Atosiban Acetate Injection Products Offered
10.23.5 Chengdu Shengnuo Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Atosiban Acetate Injection Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Atosiban Acetate Injection Industrial Chain Analysis
11.4 Atosiban Acetate Injection Market Dynamics
11.4.1 Atosiban Acetate Injection Industry Trends
11.4.2 Atosiban Acetate Injection Market Drivers
11.4.3 Atosiban Acetate Injection Market Challenges
11.4.4 Atosiban Acetate Injection Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Atosiban Acetate Injection Distributors
12.3 Atosiban Acetate Injection Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 0.9 ml
Table 2. Major Company of 5 ml
Table 3. Global Atosiban Acetate Injection Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Atosiban Acetate Injection Sales by Type (2024-2024) & (K Units)
Table 5. Global Atosiban Acetate Injection Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Atosiban Acetate Injection Sales by Type (2024-2024) & (US& Million)
Table 7. Global Atosiban Acetate Injection Market Share in Value by Type (2024-2024)
Table 8. Global Atosiban Acetate Injection Price by Type (2024-2024) & (US$/Unit)
Table 9. Global Atosiban Acetate Injection Sales by Type (2024-2034) & (K Units)
Table 10. Global Atosiban Acetate Injection Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Atosiban Acetate Injection Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Atosiban Acetate Injection Sales Market Share in Value by Type (2024-2034)
Table 13. Global Atosiban Acetate Injection Price by Type (2024-2034) & (US$/Unit)
Table 14. North America Atosiban Acetate Injection Sales by Type (2024-2024) & (K Units)
Table 15. North America Atosiban Acetate Injection Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Atosiban Acetate Injection Sales (K Units) by Type (2024-2024)
Table 17. Europe Atosiban Acetate Injection Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Atosiban Acetate Injection Sales (K Units) by Type (2024-2024)
Table 19. Asia-Pacific Atosiban Acetate Injection Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Atosiban Acetate Injection Sales (K Units) by Type (2024-2024)
Table 21. Latin America Atosiban Acetate Injection Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Atosiban Acetate Injection Sales (K Units) by Type (2024-2024)
Table 23. Middle East and Africa Atosiban Acetate Injection Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Atosiban Acetate Injection Sales by Company (2024-2024) & (K Units)
Table 25. Global Atosiban Acetate Injection Sales Share by Company (2024-2024)
Table 26. Global Atosiban Acetate Injection Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Atosiban Acetate Injection Revenue Share by Company (2024-2024)
Table 28. Global Market Atosiban Acetate Injection Price by Company (2024-2024) & (US$/Unit)
Table 29. Global Atosiban Acetate Injection Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Atosiban Acetate Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Atosiban Acetate Injection as of 2022)
Table 32. Date of Key Manufacturers Enter into Atosiban Acetate Injection Market
Table 33. Key Manufacturers Atosiban Acetate Injection Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Atosiban Acetate Injection Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Atosiban Acetate Injection Sales by Region (2024-2024) & (K Units)
Table 37. Global Atosiban Acetate Injection Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Atosiban Acetate Injection Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Atosiban Acetate Injection Sales Market Share in Value by Region (2024-2024)
Table 40. Global Atosiban Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 41. Global Atosiban Acetate Injection Sales by Region (2024-2034) & (K Units)
Table 42. Global Atosiban Acetate Injection Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Atosiban Acetate Injection Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Atosiban Acetate Injection Sales Market Share in Value by Region (2024-2034)
Table 45. Global Atosiban Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global Atosiban Acetate Injection Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Atosiban Acetate Injection Sales by Application (2024-2024) & (K Units)
Table 48. Global Atosiban Acetate Injection Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Atosiban Acetate Injection Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Atosiban Acetate Injection Sales Market Share in Value by Application (2024-2024)
Table 51. Global Atosiban Acetate Injection Price by Application (2024-2024) & (US$/Unit)
Table 52. Global Atosiban Acetate Injection Sales by Application (2024-2034) & (K Units)
Table 53. Global Atosiban Acetate Injection Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Atosiban Acetate Injection Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Atosiban Acetate Injection Sales Market Share in Value by Application (2024-2034)
Table 56. Global Atosiban Acetate Injection Price by Application (2024-2034) & (US$/Unit)
Table 57. North America Atosiban Acetate Injection Sales by Application (2024-2024) (K Units)
Table 58. North America Atosiban Acetate Injection Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Atosiban Acetate Injection Sales by Application (2024-2024) (K Units)
Table 60. Europe Atosiban Acetate Injection Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Atosiban Acetate Injection Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific Atosiban Acetate Injection Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Atosiban Acetate Injection Sales by Application (2024-2024) (K Units)
Table 64. Latin America Atosiban Acetate Injection Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Atosiban Acetate Injection Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa Atosiban Acetate Injection Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Atosiban Acetate Injection Sales by Country (2024-2024) & (K Units)
Table 68. North America Atosiban Acetate Injection Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Atosiban Acetate Injection Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Atosiban Acetate Injection Sales Market Share in Value by Country (2024-2024)
Table 71. North America Atosiban Acetate Injection Sales by Country (2024-2034) & (K Units)
Table 72. North America Atosiban Acetate Injection Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Atosiban Acetate Injection Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Atosiban Acetate Injection Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Atosiban Acetate Injection Sales by Country (2024-2024) & (K Units)
Table 76. Europe Atosiban Acetate Injection Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Atosiban Acetate Injection Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Atosiban Acetate Injection Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Atosiban Acetate Injection Sales by Country (2024-2034) & (K Units)
Table 80. Europe Atosiban Acetate Injection Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Atosiban Acetate Injection Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Atosiban Acetate Injection Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Atosiban Acetate Injection Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific Atosiban Acetate Injection Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Atosiban Acetate Injection Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Atosiban Acetate Injection Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Atosiban Acetate Injection Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Atosiban Acetate Injection Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Atosiban Acetate Injection Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Atosiban Acetate Injection Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Atosiban Acetate Injection Sales by Country (2024-2024) & (K Units)
Table 92. Latin America Atosiban Acetate Injection Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Atosiban Acetate Injection Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Atosiban Acetate Injection Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Atosiban Acetate Injection Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Atosiban Acetate Injection Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Atosiban Acetate Injection Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Atosiban Acetate Injection Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Atosiban Acetate Injection Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa Atosiban Acetate Injection Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Atosiban Acetate Injection Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Atosiban Acetate Injection Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Atosiban Acetate Injection Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Atosiban Acetate Injection Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Atosiban Acetate Injection Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Atosiban Acetate Injection Sales Market Share in Value by Country (2024-2034)
Table 107. Bachem Company Information
Table 108. Bachem Introduction and Business Overview
Table 109. Bachem Atosiban Acetate Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. Bachem Atosiban Acetate Injection Product
Table 111. Bachem Recent Development
Table 112. Piramal Pharma Solutions Company Information
Table 113. Piramal Pharma Solutions Introduction and Business Overview
Table 114. Piramal Pharma Solutions Atosiban Acetate Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. Piramal Pharma Solutions Atosiban Acetate Injection Product
Table 116. Piramal Pharma Solutions Recent Development
Table 117. Transo-Pharm Company Information
Table 118. Transo-Pharm Introduction and Business Overview
Table 119. Transo-Pharm Atosiban Acetate Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. Transo-Pharm Atosiban Acetate Injection Product
Table 121. Transo-Pharm Recent Development
Table 122. Rochem International Company Information
Table 123. Rochem International Introduction and Business Overview
Table 124. Rochem International Atosiban Acetate Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. Rochem International Atosiban Acetate Injection Product
Table 126. Rochem International Recent Development
Table 127. Suanfarma Company Information
Table 128. Suanfarma Introduction and Business Overview
Table 129. Suanfarma Atosiban Acetate Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. Suanfarma Atosiban Acetate Injection Product
Table 131. Suanfarma Recent Development
Table 132. Teva Pharmaceutical Industries Company Information
Table 133. Teva Pharmaceutical Industries Introduction and Business Overview
Table 134. Teva Pharmaceutical Industries Atosiban Acetate Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. Teva Pharmaceutical Industries Atosiban Acetate Injection Product
Table 136. Teva Pharmaceutical Industries Recent Development
Table 137. PolyPeptide Group Company Information
Table 138. PolyPeptide Group Introduction and Business Overview
Table 139. PolyPeptide Group Atosiban Acetate Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. PolyPeptide Group Atosiban Acetate Injection Product
Table 141. PolyPeptide Group Recent Development
Table 142. Emcure Pharmaceuticals Company Information
Table 143. Emcure Pharmaceuticals Introduction and Business Overview
Table 144. Emcure Pharmaceuticals Atosiban Acetate Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 145. Emcure Pharmaceuticals Atosiban Acetate Injection Product
Table 146. Emcure Pharmaceuticals Recent Development
Table 147. Smaart Pharmaceutticals Company Information
Table 148. Smaart Pharmaceutticals Introduction and Business Overview
Table 149. Smaart Pharmaceutticals Atosiban Acetate Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 150. Smaart Pharmaceutticals Atosiban Acetate Injection Product
Table 151. Smaart Pharmaceutticals Recent Development
Table 152. Omgene Life Sciences Company Information
Table 153. Omgene Life Sciences Introduction and Business Overview
Table 154. Omgene Life Sciences Atosiban Acetate Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 155. Omgene Life Sciences Atosiban Acetate Injection Product
Table 156. Omgene Life Sciences Recent Development
Table 157. BCN Peptides Company Information
Table 158. BCN Peptides Introduction and Business Overview
Table 159. BCN Peptides Atosiban Acetate Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 160. BCN Peptides Atosiban Acetate Injection Product
Table 161. BCN Peptides Recent Development
Table 162. MSN Laboratories Company Information
Table 163. MSN Laboratories Introduction and Business Overview
Table 164. MSN Laboratories Atosiban Acetate Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 165. MSN Laboratories Atosiban Acetate Injection Product
Table 166. MSN Laboratories Recent Development
Table 167. Carbosynth Company Information
Table 168. Carbosynth Introduction and Business Overview
Table 169. Carbosynth Atosiban Acetate Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 170. Carbosynth Atosiban Acetate Injection Product
Table 171. Carbosynth Recent Development
Table 172. Tecoland Company Information
Table 173. Tecoland Introduction and Business Overview
Table 174. Tecoland Atosiban Acetate Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 175. Tecoland Atosiban Acetate Injection Product
Table 176. Tecoland Recent Development
Table 177. Jigs Chemical Company Information
Table 178. Jigs Chemical Introduction and Business Overview
Table 179. Jigs Chemical Atosiban Acetate Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 180. Jigs Chemical Atosiban Acetate Injection Product
Table 181. Jigs Chemical Recent Development
Table 182. LGM Pharma Company Information
Table 183. LGM Pharma Introduction and Business Overview
Table 184. LGM Pharma Atosiban Acetate Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 185. LGM Pharma Atosiban Acetate Injection Product
Table 186. LGM Pharma Recent Development
Table 187. Hangzhou Go Top Peptide Biotech Company Information
Table 188. Hangzhou Go Top Peptide Biotech Introduction and Business Overview
Table 189. Hangzhou Go Top Peptide Biotech Atosiban Acetate Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 190. Hangzhou Go Top Peptide Biotech Atosiban Acetate Injection Product
Table 191. Hangzhou Go Top Peptide Biotech Recent Development
Table 192. Sun Pharmaceutical lndustrie Company Information
Table 193. Sun Pharmaceutical lndustrie Introduction and Business Overview
Table 194. Sun Pharmaceutical lndustrie Atosiban Acetate Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 195. Sun Pharmaceutical lndustrie Atosiban Acetate Injection Product
Table 196. Sun Pharmaceutical lndustrie Recent Development
Table 197. Hainan Zhonghe Company Information
Table 198. Hainan Zhonghe Introduction and Business Overview
Table 199. Hainan Zhonghe Atosiban Acetate Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 200. Hainan Zhonghe Atosiban Acetate Injection Product
Table 201. Hainan Zhonghe Recent Development
Table 202. Shanghai SOHO YIMING Company Information
Table 203. Shanghai SOHO YIMING Introduction and Business Overview
Table 204. Shanghai SOHO YIMING Atosiban Acetate Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 205. Shanghai SOHO YIMING Atosiban Acetate Injection Product
Table 206. Shanghai SOHO YIMING Recent Development
Table 207. Hybio Pharmaceutical Company Information
Table 208. Hybio Pharmaceutical Introduction and Business Overview
Table 209. Hybio Pharmaceutical Atosiban Acetate Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 210. Hybio Pharmaceutical Atosiban Acetate Injection Product
Table 211. Hybio Pharmaceutical Recent Development
Table 212. Hainan Herui Company Information
Table 213. Hainan Herui Introduction and Business Overview
Table 214. Hainan Herui Atosiban Acetate Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 215. Hainan Herui Atosiban Acetate Injection Product
Table 216. Hainan Herui Recent Development
Table 217. Chengdu Shengnuo Company Information
Table 218. Chengdu Shengnuo Introduction and Business Overview
Table 219. Chengdu Shengnuo Atosiban Acetate Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 220. Chengdu Shengnuo Atosiban Acetate Injection Product
Table 221. Chengdu Shengnuo Recent Development
Table 222. Key Raw Materials Lists
Table 223. Raw Materials Key Suppliers Lists
Table 224. Atosiban Acetate Injection Market Trends
Table 225. Atosiban Acetate Injection Market Drivers
Table 226. Atosiban Acetate Injection Market Challenges
Table 227. Atosiban Acetate Injection Market Restraints
Table 228. Atosiban Acetate Injection Distributors List
Table 229. Atosiban Acetate Injection Downstream Customers
Table 230. Research Programs/Design for This Report
Table 231. Key Data Information from Secondary Sources
Table 232. Key Data Information from Primary Sources
List of Figures
Figure 1. Atosiban Acetate Injection Product Picture
Figure 2. Global Atosiban Acetate Injection Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Atosiban Acetate Injection Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Atosiban Acetate Injection Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of 0.9 ml
Figure 6. Global 0.9 ml Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of 5 ml
Figure 8. Global 5 ml Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global Atosiban Acetate Injection Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Atosiban Acetate Injection Sales Market Share by Type in 2022 & 2034
Figure 11. North America Atosiban Acetate Injection Sales Market Share in Volume by Type in 2022
Figure 12. North America Atosiban Acetate Injection Sales Market Share in Value by Type in 2022
Figure 13. Europe Atosiban Acetate Injection Sales Market Share in Volume by Type in 2022
Figure 14. Europe Atosiban Acetate Injection Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Atosiban Acetate Injection Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Atosiban Acetate Injection Sales Market Share in Value by Type in 2022
Figure 17. Latin America Atosiban Acetate Injection Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Atosiban Acetate Injection Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Atosiban Acetate Injection Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Atosiban Acetate Injection Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Atosiban Acetate Injection Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Atosiban Acetate Injection Revenue in 2022
Figure 23. Atosiban Acetate Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Threatened Preterm Birth
Figure 25. Global Threatened Preterm Birth Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of Inhibits Lactation
Figure 27. Global Inhibits Lactation Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Others
Figure 29. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Global Atosiban Acetate Injection Sales by Application (2024-2034) & (US$ Million)
Figure 31. Global Atosiban Acetate Injection Sales Market Share by Application in 2022 & 2034
Figure 32. North America Atosiban Acetate Injection Sales Market Share in Volume by Application in 2022
Figure 33. North America Atosiban Acetate Injection Sales Market Share in Value by Application in 2022
Figure 34. Europe Atosiban Acetate Injection Sales Market Share in Volume by Application in 2022
Figure 35. Europe Atosiban Acetate Injection Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Atosiban Acetate Injection Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Atosiban Acetate Injection Sales Market Share in Value by Application in 2022
Figure 38. Latin America Atosiban Acetate Injection Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Atosiban Acetate Injection Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Atosiban Acetate Injection Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Atosiban Acetate Injection Manufacturing Cost Structure
Figure 43. Atosiban Acetate Injection Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed